用于心房颤动和心力衰竭患者的地高辛：失乐园与否？ - Suppr

Suppr

超能文献

Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?

作者信息

van Veldhuisen Dirk J, Van Gelder Isabelle C, Ahmed Ali, Gheorghiade Mihai

出版信息

Eur Heart J. 2013 May;34(20):1468-70. doi: 10.1093/eurheartj/ehs483. Epub 2013 Jan 16.

DOI:10.1093/eurheartj/ehs483

PMID:23324547

Abstract

摘要

相似文献

Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?用于心房颤动和心力衰竭患者的地高辛：失乐园与否？

Eur Heart J. 2013 May;34(20):1468-70. doi: 10.1093/eurheartj/ehs483. Epub 2013 Jan 16.

Digoxin use in atrial fibrillation.

J Miss State Med Assoc. 2013 Sep;54(9):258-9.

When 'digoxin use' is not the same as 'digoxin use': lessons from the AFFIRM trial.

Eur Heart J. 2013 May;34(20):1465-7. doi: 10.1093/eurheartj/eht087. Epub 2013 Apr 16.

Digoxin mortality in heart failure and atrial fibrillation.

Eur Heart J. 2015 Aug 7;36(30):1944-5.

Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.地高辛对心力衰竭分层的心房颤动患者死亡率的影响：中东地区心房颤动事件海湾调查结果

J Cardiovasc Pharmacol Ther. 2016 May;21(3):273-9. doi: 10.1177/1074248415603505. Epub 2015 Sep 3.

Use of digoxin for heart failure and atrial fibrillation in elderly patients.地高辛在老年患者心力衰竭和心房颤动中的应用。

Am J Geriatr Pharmacother. 2010 Oct;8(5):419-27. doi: 10.1016/j.amjopharm.2010.10.001.

Is there a role for digoxin in atrial fibrillation without heart failure?地高辛在无心力衰竭的心房颤动中是否有作用？

Cardiol J. 2009;16(5):483-6.

Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation.

J Hypertens. 2015 Jul;33(7):1371-2. doi: 10.1097/HJH.0000000000000628.

Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.无论是否合并心力衰竭，地高辛与房颤患者全因死亡率增加相关：一项荟萃分析。

J Cardiovasc Pharmacol. 2015 Sep;66(3):270-5. doi: 10.1097/FJC.0000000000000274.

Bidirectional ventricular tachycardia resulting from digoxin and amiodarone treatment of rapid atrial fibrillation.

Am J Emerg Med. 2004 May;22(3):235-6. doi: 10.1016/j.ajem.2004.02.034.

引用本文的文献

Meta-Analysis of Catheter Ablation versus Medical Therapy for Heart Failure Complicated with Atrial Fibrillation.导管消融术与药物治疗心力衰竭合并心房颤动的Meta分析

Cardiol Res Pract. 2021 Dec 6;2021:7245390. doi: 10.1155/2021/7245390. eCollection 2021.

Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.2型糖尿病和糖尿病前期患者心血管疾病的诊断、预防及治疗：日本循环学会和日本糖尿病学会联合共识声明

Diabetol Int. 2020 Nov 30;12(1):1-51. doi: 10.1007/s13340-020-00471-5. eCollection 2021 Jan.

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation.窦性心律与心房颤动的射血分数降低的心力衰竭患者β受体阻滞剂滴定后心率变化对预后的意义。

Clin Res Cardiol. 2019 Jul;108(7):797-805. doi: 10.1007/s00392-018-1409-x. Epub 2019 Jan 4.

Status of cardiac arrhythmia services in Africa in 2018: a PASCAR Sudden Cardiac Death Task Force report.2018年非洲心律失常服务状况：泛非洲猝死特别工作组报告

Cardiovasc J Afr. 2018 Mar/Apr;29(2):115-121. doi: 10.5830/CVJA-2018-027.

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.心脏移植前患者接受慢性洋地黄治疗是移植后死亡率增加的独立危险因素。

Ther Clin Risk Manag. 2017 Oct 13;13:1399-1407. doi: 10.2147/TCRM.S147062. eCollection 2017.

Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?AFFIRM试验事后分析得出的相反结论：是倾向评分分析的问题还是只是无辜的受害者？

Ther Adv Drug Saf. 2014 Feb;5(1):4-7. doi: 10.1177/2042098613517416.

[Digitalis and theophylline: old and superfluous?].洋地黄和茶碱：过时且多余？

Z Gerontol Geriatr. 2013 Jul;46(5):479-86; quiz 486-7. doi: 10.1007/s00391-013-0497-5.

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.在服用地高辛的心房颤动患者中，没有增加死亡率的证据：来自 AFFIRM 试验事后倾向匹配分析的结果。

Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验